Life Science Insights Top Ten List for 2005

From Bio-It World

"The outlook for 2005 is one of “cautious optimism,” with an increased emphasis on issues of compliance, pharmacovigilance, outsourcing, and the pharma CIO. Those were some of the key takeaways of the first annual Life Science Insights (LSI) Predictions for the life sciences industry, delivered today by Jim Golden, vice president for research....

And so with apologies to David Letterman, the LSI Top Ten list for 2005:

1. Technology growth later in the value chain...
2. Disaggregation happens...
3. Innovation will happen - somewhere else...
4. The line between IT and drug discovery . . . will continue to blur...
5. Thus, the rise of the Pharma CIO...
6. Data standards will drive a fragmented industry...
7. The curse of Eliot Spitzer...
8. Pharmacovigilance...
9. Lost on the NIH Roadmap...
10. Venture capital is back"